Treatment of Nodular Lymphocyte Hodgkin Lymphoma: The Goldilocks Principle

被引:2
作者
Bartlett, Nancy L. [1 ]
机构
[1] Washington Univ, Med Ctr, St Louis, MO USA
关键词
INVOLVED-FIELD RADIOTHERAPY; EUROPEAN TASK-FORCE; INTENSITY CHEMOTHERAPY; FINAL ANALYSIS; OPEN-LABEL; LONG-TERM; PREDOMINANT; ABVD; DISEASE; TRANSFORMATION;
D O I
10.1200/JCO.19.02816
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
引用
收藏
页码:662 / +
页数:8
相关论文
共 41 条
[21]   Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group [J].
Eichenauer, Dennis A. ;
Fuchs, Michael ;
Pluetschow, Annette ;
Klimm, Beate ;
Halbsguth, Teresa ;
Boell, Boris ;
Von Tresckow, Bastian ;
Nogova, Lucia ;
Borchmann, Peter ;
Engert, Andreas .
BLOOD, 2011, 118 (16) :4363-4365
[22]   Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group [J].
Engert, A ;
Schiller, P ;
Josting, A ;
Herrmann, R ;
Koch, P ;
Sieber, M ;
Boissevain, F ;
de Wit, M ;
Mezger, J ;
Dühmke, E ;
Willich, N ;
Müller, RP ;
Schmidt, BF ;
Renner, H ;
Müller-Hermelink, HK ;
Pfistner, B ;
Wolf, J ;
Hasenclever, D ;
Löffler, M ;
Diehl, V .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3601-3608
[23]   Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma:: Final results of the GHSG HD7 trial [J].
Engert, Andreas ;
Franklin, Jeremy ;
Eich, Hans Theodor ;
Brillant, Corinne ;
Sehlen, Susanne ;
Cartoni, Claudio ;
Herrmann, Richard ;
Pfreundschuh, Michael ;
Sieber, Markus ;
Tesch, Hans ;
Franke, Astrid ;
Koch, Peter ;
de Wit, Maike ;
Paulus, Ursula ;
Hasenclever, Dirk ;
Loeffler, Markus ;
Mueller, Rolf-Peter ;
Mueller-Hermelink, Hans Konrad ;
Duehmke, Eckhart ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) :3495-3502
[24]   Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial [J].
Engert, Andreas ;
Haverkamp, Heinz ;
Kobe, Carsten ;
Markova, Jana ;
Renner, Christoph ;
Ho, Antony ;
Zijlstra, Josee ;
Kral, Zdenek ;
Fuchs, Michael ;
Hallek, Michael ;
Kanz, Lothar ;
Doehner, Hartmut ;
Doerken, Bernd ;
Engel, Nicole ;
Topp, Max ;
Klutmann, Susanne ;
Amthauer, Holger ;
Bockisch, Andreas ;
Kluge, Regine ;
Kratochwil, Clemens ;
Schober, Otmar ;
Greil, Richard ;
Andreesen, Reinhard ;
Kneba, Michael ;
Pfreundschuh, Michael ;
Stein, Harald ;
Eich, Hans Theodor ;
Mueller, Rolf-Peter ;
Dietlein, Markus ;
Borchmann, Peter ;
Diehl, Volker .
LANCET, 2012, 379 (9828) :1791-1799
[25]   Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma [J].
Engert, Andreas ;
Pluetschow, Annette ;
Eich, Hans Theodor ;
Lohri, Andreas ;
Doerken, Bernd ;
Borchmann, Peter ;
Berger, Bernhard ;
Greil, Richard ;
Willborn, Kay C. ;
Wilhelm, Martin ;
Debus, Juergen ;
Eble, Michael J. ;
Soekler, Martin ;
Ho, Antony ;
Rank, Andreas ;
Ganser, Arnold ;
Truemper, Lorenz ;
Bokemeyer, Carsten ;
Kirchner, Hartmut ;
Schubert, Joerg ;
Kral, Zdenek ;
Fuchs, Michael ;
Mueller-Hermelink, Hans-Konrad ;
Mueller, Rolf-Peter ;
Diehl, Volker .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (07) :640-652
[26]   Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma [J].
Fanale, Michelle A. ;
Cheah, Chan Yoon ;
Rich, Amy ;
Medeiros, L. Jeffrey ;
Lai, Chao-Ming ;
Oki, Yasuhiro ;
Romaguera, Jorge E. ;
Fayad, Luis E. ;
Hagemeister, F. B. ;
Samaniego, Felipe ;
Rodriguez, Maria A. ;
Neelapu, Sattva S. ;
Lee, Hun J. ;
Nastoupil, Loretta ;
Fowler, Nathan H. ;
Turturro, Francesco ;
Westin, Jason R. ;
Wang, Michael L. ;
McLaughlin, Peter ;
Pinnix, Chelsea C. ;
Milgrom, Sarah A. ;
Dabaja, Bouthaina ;
Horowitz, Sandra B. ;
Younes, Anas .
BLOOD, 2017, 130 (04) :472-477
[27]   Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma [J].
Hartmann, Sylvia ;
Doering, Claudia ;
Vucic, Emily ;
Chan, Fong Chun ;
Ennishi, Daisuke ;
Tousseyn, Thomas ;
de Wolf-Peeters, Christiane ;
Perner, Sven ;
Wlodarska, Iwona ;
Steidl, Christian ;
Gascoyne, Randy D. ;
Hansmann, Martin-Leo .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (03) :415-422
[28]   Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution [J].
Kenderian, Saad Sirop ;
Habermann, Thomas M. ;
Macon, William R. ;
Ristow, Kay M. ;
Ansell, Stephen M. ;
Colgan, Joseph P. ;
Johnston, Patrick B. ;
Inwards, David J. ;
Markovic, Svetomir N. ;
Micallef, Ivana N. ;
Thompson, Carrie A. ;
Porrata, Luis F. ;
Martenson, James A. ;
Witzig, Thomas E. ;
Nowakowski, Grzegorz S. .
BLOOD, 2016, 127 (16) :1960-1966
[29]   What Is the Appropriate Systemic Chemotherapy for Lymphocyte-Predominant Hodgkin's Lymphoma? [J].
Mauch, Peter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :E8-E8
[30]   Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma [J].
McKay, Pamela ;
Fielding, Patrick ;
Gallop-Evans, Eve ;
Hall, Georgina W. ;
Lambert, Jonathan ;
Leach, Mike ;
Marafioti, Teresa ;
McNamara, Christopher .
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (01) :32-43